Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Lilly Announces Results From SURMOUNT-1 Three-Year Study Of Tirzepatide, Showing Weekly Tirzepatide Injections Reduced Risk Of Progression To Type 2 Diabetes By 94% In Adults With Pre-Diabetes And Obesity

Author: Benzinga Newsdesk | August 20, 2024 06:52am

Posted In: LLY